7 Mar 2023
SHRO’s Giordano to Speak at Virtual Workshop on Artificial Intelligence in Medicine
Originally published in Newswise Newswise — March 7, 2023, Philadelphia –...
22 Feb 2023
Cancer: In Italy every year over 8000 patients candidates for liquid biopsy
Rome, 21 February 2023 – Almost 8,000 lung cancer patients...
24 Jan 2023
Malfunctioning Mitochondria at the Heart of Many Cardiovascular Diseases
NewswiseMany cardiovascular diseases, such as atherosclerosis, or ‘hardening of the...
22 Dec 2022
Are the Benefits of New Cancer Drugs Worth the Cost?
Newswise — An international research group including scientists from Italy, the...
29 Nov 2022
Links Between Neurological Involvement and Respiratory Damage in SARS-CoV-2 Infection
Newswise — Researchers working with Sbarro Health Research Organization (SHRO) have...
31 Oct 2022
Dr. Giordano meets Speaker Nancy Pelosi, De Laurentiis & Petrone at the 47th anniversary of NIAF
Professor Antonio Giordano founder of Sbarro Health Research Organization (SHRO) meet...
28 Oct 2022
Cellular Cilium an Early Sign of Mesothelioma Differentiation
As Published on Newswise — A new study investigated the expression...
12 Oct 2022
Adverse Events Linked to PD-1 Blockade in Some Lung Cancer Patients
Original Newswise post Newswise — Treatments with PD-1/PD-L1 immuno-checkpoint inhibitors...
26 Sep 2022
Among the causes of type 1 diabetes is a newly discovered bacterium
Analyzing the inflammatory profile of 54 patients who underwent biopsy,...
15 Sep 2022
Predicting Outcomes for Rare Form of Bladder Cancer with Metastatic Tumors
Original Newswise post Newswise — A team of investigators from...
31 Aug 2022
Molecular Medicine Review Reveals the Role of IGF in Cancer, Other Proliferative Disease
Newswise — Studies suggest that Insulin-Like Growth Factor (IGF) plays...
18 Aug 2022
Immunotherapy Covered in Special Edition of Current Clinical Pathology
Newswise — In the latest Current Clinical Pathology publication on...